- Investopedia•3 hours ago
Big pharma companies eagerly await key decisions on drugs from the FDA next week.
- Investopedia•7 hours ago
Breakthrough designation will help faster review of Rituxan for treating rare disease Pemphigus Vulgaris
- Investopedia•8 hours ago
Bavencio, the first and only approved drug for MCC treatment, is under study for multiple other cancers.
RHHBY : Summary for ROCHE HLDG LTD SPONS - Yahoo Finance
Roche Holding AG (RHHBY)
Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
|Day's Range||31.77 - 32.03|
|52 Week Range||25.25 - 33.77|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||23.13|
|Dividend & Yield||1.02 (3.23%)|
|1y Target Est||N/A|